Although not predictive of the development of SBP, the presence of bacterial DNA in ascitic fluid and serum is an indicator of a poor prognosis necessitating further investigation. [72] ...

In 1991, Soriano et al. [16] published the first study on the use of norfloxacin to prevent an episode of SBP in patients with cirrhosis and low ascitic fluid total protein concentration (<1.5 g/dL).

Spontaneous bacterial peritonitis (SBP) is a serious infection that occurs in patients with liver cirrhosis, particularly those who have developed ascites, which is the accumulation of fluid in ...